Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
308 patients out of 340 !! So be it !!
How can they know ? To paraphrase Jeff Goldblum from JP, “Information .... finds a way”
Everybody else shuts up and disappears after I show up.
If Nader says 2-3 weeks, double it ! Aug 14-28
Great site : www.nashbiotechs.com
Projects about $5Billion for GR-MD-02 revenues way down the road
Yes, but for what reason ? He’s not necessarily out for money, but he’s on a mission. Members of his family died from cancer while he was still young. He wants to slay that dragon.
On the issue of Dr Pestell I am a Jet. Excuse me while I crouch down and snap my fingers.
No, they have never been CLOSE to any time projection that I can recall in 2.5 years. That is why I have been selling some CYDY. Without further developments, I would sell more by November. Fortunately, I expect things to happen this fall.
If Pestell brings the Big Financing .... yes. I would say it’s likely that he brings financing with him almost as soon as he signs.
I don’t understand all of that; but I suspect we’re not supposed to.
The Stock Twits board is busy
Is your name John Snow ? Because you know nothing.
Can you keep a link to this video at the top of the board ?
Nader’s time estimates : if he says 2-3 weeks, it will be 4-5 weeks.
The trend from May 2016 continues
Hello Paulson my non-friend .... I don’t want to talk to you again .... a vision softly creeping ... that prevents me from sleeping.
But TPIV will only own about 30% of the combined company, right ? Trying to remember algebra .... so TPIV shares may be $600 Mill at buyout ( if $2B ) TPIV is $100 Mill now. And fully funded at merger !! Time to buyout : a few to several quarters. A few bagger in a few quarters. Sounds good.
Could this get a “Sticky” ?
I actually bought a stock and it didn’t immediately DROP 10% but went UP 10% ?? The world must be about to end.
So on 10,000 shares that difference is .... a nickel.
Back to 6 digits on the stock price ?
Technically, that is true and if funding were (conditional tense) not solved we could be lower next year. But what is different now from 12 months ago ? We have PE in combo, we have a path set for BLA and it seems clear that we will *eventually* have 70+% suppression in mono. And we have a world-leading cancer researcher. All of that is a big deal. Deals.
Retail can’t POSSIBLY drive the stock. Only trigger will be FDA approval or licensing or a $80 million loan. Nothing less.
The stock dropped as if it was 8-1 regular split. The company must have lost 98% if it’s value like HMNY.
Is anyone else doing this ? I thought maybe OSE (in Paris) was.
That’s what Bloomberg says
About the Only things you wanna pay off are trial costs, CMC, and Dr Pestell.
Samsung makes first biologic Samsung ??
https://www.biopharma-reporter.com/Article/2018/07/27/Samsung-BioLogics-approved-to-make-first-mAb-for-US-market
Merck gets 73% suppression in 96 week HIV trial
Biotech Analysis Central Pharma News: Merck's HIV Results, Biogen's Partnership, Eli Lilly's $1 Billion Dealhttps://seekingalpha.com/article/4192259
But this is not multi-drug resistant patient population
You’re welcome, guys ! That video was why I bought my first shares today. They have superior treatments than $10B companies
Combo had the PE after 1 week, not mono. ALL OF THE MONO OUTCOMES are 48 weeks according to clinical trials gov.
Yes, but 700 mg patients will not be finished for AT LEAST 48 weeks, because they are still enrolling. Mono is going to continue until early next fall. BLA is delayed , IMO, also. So there’s a reason for BP to hold off on any sort of deal just yet. They shouldn’t but I think they will. Meanwhile timelines are sliding due to funding. That could change, but I’m not that sure the company will ink any deal. I’m reasonably sure that some funding will come for cancer, but can they use some of that for HIV instead ?
With 6 employees ? They are not going to; how could they ?
I would consider the possibility that the company would still be floundering a year from now to be nearly as likely as a $5B buyout ... given the company’s history. The company will HAVE to execute on their plans. I am not confident about that.
And that was 2 weeks ago. So hopefully this week.
There’s been a fair amount of dilution since then, so fully diluted $16 then wouldn’t be $16 now.
So they time to buy is when they no longer have a need to dilute ?